UCLA study to determine if copper surfaces can reduce hospital-acquired infections

July 9, 2012 in Diseases, Conditions, Syndromes

Hospital-acquired infections are a huge public health burden, and hospital environments play a key role in harboring potentially deadly bacteria such as E. coli, C. difficile and methicillin-resistant Staphylococcus aureus.

These microbes may persist for extended periods in the hospital, on surfaces such as bed rails, doorknobs, chairs, tray tables, and even call buttons in patient rooms.

Copper surfaces, which are not routinely used in hospitals, are known to kill bacteria on contact, and studies have found much lower levels of bacteria living on copper surfaces than on standard hospital surfaces.

Now, an interdisciplinary team from UCLA is taking this research to the next level. In one of the first randomized clinical trials of its kind, researchers will determine if the reduction of bacteria due to the use of copper will result in a decreased number of .

Funding for the $2.5 million study will be provided by an RO1 grant (HS021188-01) from the Agency for Healthcare Research and Quality, part of the U.S. Department of Health and Human Services. The project will involve teams from the David Geffen School of Medicine at UCLA, the UCLA Fielding School of Public Health and the Henry Samueli School of Engineering and Applied Science. The collaborative research initiative is a project of the UCLA Sustainable Technology and Policy Program.

For the clinical trial, two intensive care units at Ronald Reagan UCLA Medical Center will be outfitted with copper, sham stainless steel, or conventional surfaces such as plastic or other types of coatings. Over a four-year period, all three surface types will be sampled for bacteria levels, and patient-infection outcomes rates will be compared among the three surfaces.

"We will be studying if lowering the level of bacteria on hospital surfaces results in reduced infection rates in patients, better outcomes and even lower costs," said the project's principal investigator, Dr. Daniel Uslan, director of the antimicrobial stewardship program at the Geffen School of Medicine and an assistant clinical professor of medicine in the division of infectious diseases.

Additional environmental microbiologic studies and evaluations of surface cleaning will be included in the research, as well as a detailed cost–benefit analysis.

Dr. Peter Sinsheimer, executive director of the UCLA Sustainable Technology and Policy Program, a joint initiative of the Fielding School of Public Health and the UCLA School of Law, helped arrange the interdisciplinary collaborations.

"Being at UCLA makes it easy to pull together diverse teams of top-flight scientists to conduct such important prevention-based research," said Sinsheimer, whose program focuses on primary health prevention through materials substitution.

The initial idea for the hospital-based study came from Sinsheimer's research on the viability of alternatives to lead-based copper piping in delivering safer drinking water.

Hospital surfaces selected for the study will include bed rails, chairs, a bedside table that can also be positioned on top of the bed, and a mobile treatment cart-top used by nursing staff that includes handles, a keyboard and a mouse.

A team at UCLA Engineering will assist with the testing of the copper and other surfaces used in the clinical trial.

"We will be incorporating copper, plastic or sham stainless steel materials into the selected everyday surfaces used by patients and staff in the hospital," said Vijay Gupta, a professor of mechanical and aerospace engineering.

The cost-effectiveness analysis will be conducted by Dr. Gerald Kominski, director of the UCLA Center for Health Policy Research and a professor in the department of health policy and management at the Fielding School of .

"Finding effective interventions to reduce hospital infection rates in a cost-effective manner is an emerging priority for U.S. hospitals," Kominski said. "This study will provide valuable information on whether copper-touch surfaces are a cost-effective technology for achieving this goal."

Provided by University of California, Los Angeles search and more info website

not rated yet  

Filter


Move the slider to adjust rank threshold, so that you can hide some of the comments.


Display comments: newest first

copperkeyboard
Aug 02, 2012

Rank: not rated yet
Operator Interface Technology would be a good source for copper keyboards for your trial
Rank not rated yet
Related Stories
Relevant PhysicsForums posts

More news stories

FDA warns of infections tied to Tennessee pharmacy

(AP)—Government health officials are investigating several health problems reported with potentially contaminated medications made by a Tennessee specialty pharmacy.

Diseases, Conditions, Syndromes created 20 hours ago | popularity not rated yet | comments 0

Comorbidities common with alopecia areata

(HealthDay)—Comorbid conditions often accompany alopecia areata, according to a study published online May 22 in JAMA Dermatology.

Diseases, Conditions, Syndromes created 21 hours ago | popularity not rated yet | comments 0

Top-ranked golfer beats scoliosis

(HealthDay)—As a world-class golfer, Stacy Lewis' accomplishments are remarkable. But it was a physical challenge in her childhood that defined her ascent to the top of her sport.

Diseases, Conditions, Syndromes created 22 hours ago | popularity not rated yet | comments 0

Saudi to send animal samples to US in coronavirus probe (Update)

Saudi Arabia said Friday it would send samples taken from animals possibly infected with a deadly SARS-like virus to the United States for testing in a bid to find the source of disease.

Diseases, Conditions, Syndromes created May 24, 2013 | popularity not rated yet | comments 0

WHO voices deep concern over spread of SARS-like virus

The World Health Organization voiced deep concern Thursday over the SARS-like virus that has killed 22 people in less than a year, saying it might potentially spread more widely between humans.

Diseases, Conditions, Syndromes created May 24, 2013 | popularity 5 / 5 (1) | comments 0


First drug to improve heart failure mortality in over a decade

Coenzyme Q10 decreases all cause mortality by half, according to the results of a multicentre randomised double blind trial presented today at Heart Failure 2013 congress. It is the first drug to improve heart failure mortality ...

Hormone levels may provide key to understanding psychological disorders in women

Women at a particular stage in their monthly menstrual cycle may be more vulnerable to some of the psychological side-effects associated with stressful experiences, according to a study from UCL.

Heart failure accelerates male 'menopause'

Heart failure accelerates the aging process and brings on early andropausal syndrome (AS), according to research presented today at the Heart Failure Congress 2013. AS, also referred to as male 'menopause', was four times ...

Researchers identify first drug targets in childhood genetic tumor disorder

Two mutations central to the development of infantile myofibromatosis (IM)—a disorder characterized by multiple tumors involving the skin, bone, and soft tissue—may provide new therapeutic targets, according to researchers ...

Going live: Immune cell activation in multiple sclerosis

Biological processes are generally based on events at the molecular and cellular level. To understand what happens in the course of infections, diseases or normal bodily functions, scientists would need to ...

Feds fight morning-after pill age ruling in NY

(AP)—Department of Justice lawyers have again asked a federal appeals court in New York to delay lifting age restrictions and prescription requirements on an emergency contraceptive popularly known as the morning-after ...